Format

Send to

Choose Destination
Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):445-51. doi: 10.1586/egh.09.32.

Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

Author information

1
Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is currently the most common form of chronic liver disease affecting both adults and children in the USA and many other parts of the world. NAFLD encompasses a wide spectrum of conditions associated with the overaccumulation of lipids in the liver, ranging from steatosis to nonalcoholic steatohepatitis, to cirrhosis and its feared complications of portal hypertension, liver failure and hepatocellular carcinoma. In this article, we will focus on the growing evidence linking changes in hepatic lipid metabolism and accumulation of specific lipid types in the liver with hepatocellular damage, inflammation and apoptosis, resulting in disease progression to the more serious forms of this condition.

PMID:
19673631
PMCID:
PMC2775708
DOI:
10.1586/egh.09.32
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center